Correction: Oral ponesimod in relapsing-remitting multiple sclerosis: A randomised phase II trial(Journal of Neurology, Neurosurgery and Psychiatry DOI: 10.1136/jnnp-2013-307282)

Authors
Category Primary study
JournalJournal of Neurology, Neurosurgery and Psychiatry
Year 2019
This article has no abstract
Epistemonikos ID: c20c29fbb0deed36925a9952bc937b53bfd2262a
First added on: Mar 31, 2022